Department of Microbiology, Faculty of Medicine, Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Curr Drug Discov Technol. 2023;20(1):e050822207324. doi: 10.2174/1570163819666220805161821.
One of the major problems with Brucella infections is its tendency to become chronic and recurrent, providing a hindrance to the management of this infection. It has been proposed that chronicity is greatly affected by a phenomenon called persistence in bacteria. Several mechanisms are involved in bacterial persistence, including the type II toxin-antitoxin system, the SOS and oxidative and stringent responses.
In this in silico study, these persistence mechanisms in Brucella spp. were investigated.
The structure and the interactions between modules involved in these systems were designed, and novel peptides that can interfere with some of these important mechanisms were developed.
Since peptide-based therapeutics are a new and evolving field due to their ease of production, we hope that peptides developed in this study, as well as the information about the structure and interactions of modules of persistence mechanisms, can further be used to design drugs against Brucella persister cells in the hope of restraining the chronic nature of Brucellosis.
布鲁氏菌感染的主要问题之一是其易于慢性化和复发性,这给这种感染的治疗带来了困难。有人提出,慢性化在很大程度上受到细菌中一种称为持续性的现象的影响。细菌持续性涉及几种机制,包括 II 型毒素-抗毒素系统、SOS 和氧化及严格反应。
在这项计算机模拟研究中,研究了布鲁氏菌属中这些持续性机制。
设计了这些系统中涉及的模块的结构和相互作用,并开发了可以干扰其中一些重要机制的新型肽。
由于基于肽的治疗方法因其易于生产而成为一个新的不断发展的领域,我们希望本研究中开发的肽以及关于持续性机制模块的结构和相互作用的信息,可以进一步用于设计针对布鲁氏菌持久细胞的药物,以期抑制布鲁氏菌病的慢性性质。